Literature DB >> 15351061

Simple and rapid HPLC method for determination of amlodipine in human serum with fluorescence detection and its use in pharmacokinetic studies.

Gh Bahrami1, Sh Mirzaeei.   

Abstract

A fast, sensitive and specific high performance liquid chromatographic method using fluorescence detection is described for analysis of amlodipine in human serum. Amlodipine is extracted from serum by ethyl acetate and involves precolumn derivatization with 4-chloro-7-nitrobenzofurazan (NBD-Cl) and reverse-phase chromatography on C18 column. The mobile phase was sodium phosphate buffer (pH 2.5) containing 1 ml/l triethylamine and methanol at flow rate of 2.8 ml/min. Propranolol was used as internal standard. The standard curve was linear over the range 0.25-16 ng/ml of amlodipine in human serum. The within-day and between-day precision studies showed good reproducibility with coefficients of variation less than 12% for all the analytes. The limit of quantification was 0.25 ng/ml of serum. The method has been applied to a bioequivalence study after administration of 10 mg amlodipine in 12 normal subjects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351061     DOI: 10.1016/j.jpba.2004.05.016

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  9 in total

1.  Multivariate versus classical univariate calibration methods for spectrofluorimetric data: application to simultaneous determination of olmesartan medoxamil and amlodipine besylate in their combined dosage form.

Authors:  Hany W Darwish; Ahmed H Backeit
Journal:  J Fluoresc       Date:  2012-08-16       Impact factor: 2.217

2.  Effect of ABCB1 (MDR1) haplotypes derived from G2677T/C3435T on the pharmacokinetics of amlodipine in healthy subjects.

Authors:  Kyoung-Ah Kim; Pil-Whan Park; Ji-Young Park
Journal:  Br J Clin Pharmacol       Date:  2006-07-21       Impact factor: 4.335

3.  Simultaneous Quantitative Analysis of Olmesartan Medoxomil and Amlodipine Besylate in Plasma by High-performance Liquid Chromatography Technique.

Authors:  S Shah; A Asnani; D Kawade; S Dangre; S Arora; S Yende
Journal:  J Young Pharm       Date:  2012-04

4.  Simultaneous determination of amlodipine and valsartan.

Authors:  Nashwah Gadallah Mohamed
Journal:  Anal Chem Insights       Date:  2011-08-28

5.  Development and Validation of a LC-MS/MS Method for the Simultaneous Estimation of Amlodipine and Valsartan in Human Plasma: Application to a Bioequivalence Study.

Authors:  Hemanth Jangala; Poonam Vats; Arshad Hussain Khuroo; Tausif Monif
Journal:  Sci Pharm       Date:  2014-03-26

6.  Simultaneous determination of amlodipine, valsartan and hydrochlorothiazide by LC-ESI-MS/MS and its application to pharmacokinetics in rats.

Authors:  Shankar Ganesh Gadepalli; Pragney Deme; Madhusudana Kuncha; Ramakrishna Sistla
Journal:  J Pharm Anal       Date:  2013-12-19

7.  Estimation of Amlodipine Besylate, Valsartan and Hydrochlorothiazide in Bulk Mixture and Tablet by UV Spectrophotometry.

Authors:  Varsha R Galande; K G Baheti; S Indraksha; M H Dehghan
Journal:  Indian J Pharm Sci       Date:  2012-01       Impact factor: 0.975

8.  Development of Validated Bioanalytical HPLC-UV Method for Simultaneous Estimation of Amlodipine and Atorvastatin in Rat Plasma.

Authors:  G S Talele; P K Porwal
Journal:  Indian J Pharm Sci       Date:  2015 Nov-Dec       Impact factor: 0.975

9.  Development of UV spectrophotometry methods for concurrent quantification of amlodipine and celecoxib by manipulation of ratio spectra in pure and pharmaceutical formulation.

Authors:  Mahesh Attimarad; Venugopla Katarigatta Narayanswamy; Bandar Essa Aldhubaib; Nagaraja SreeHarsha; Anroop Balachandran Nair
Journal:  PLoS One       Date:  2019-09-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.